| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/13/2001 | WO2001066126A1 Sialoadhesin factor-2 antibodies |
| 09/13/2001 | WO2001066125A1 DNA ENCODING HUMAN ACID-SENSING ION CHANNEL BNaC4 (ASIC4) |
| 09/13/2001 | WO2001066124A2 Composition for the treatment of heart failure |
| 09/13/2001 | WO2001066107A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 09/13/2001 | WO2001066063A2 Ve-cadherin and vegfr-2 antagonists for therapeutic modulation of angiogenesis |
| 09/13/2001 | WO2001065998A2 Methods for the diagnosis and treatment of breast cancer |
| 09/13/2001 | WO2001029178A3 Epo primary response gene 1, eprg1 |
| 09/13/2001 | WO2001016288A3 Dna encoding the human serine protease c-e |
| 09/13/2001 | WO2001016180A3 Cd40 agonist compositions and methods of use |
| 09/13/2001 | WO2001011010A3 Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene |
| 09/13/2001 | WO2000063370A3 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes |
| 09/13/2001 | WO2000062795A3 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS |
| 09/13/2001 | WO2000043790A9 Compositions and methods for the diagnosis and treatment of tumor |
| 09/13/2001 | WO2000034780A8 METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ¿3? |
| 09/13/2001 | WO1995021922A3 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use |
| 09/13/2001 | US20010021771 Human doppel polypeptide; genetic engineering |
| 09/13/2001 | US20010021769 Cell culture product |
| 09/13/2001 | US20010021702 Newly identified polypeptides and polynucleotides that encode them; used in identifying compounds which may be agonists, antagonists and/or inhbitors which are can be useful in therapy |
| 09/13/2001 | US20010021700 Vectors, host cells, antibodies, and recombinant and synthetic methods for producing polynucleotides and the polypeptides they encode |
| 09/13/2001 | US20010021517 An isolated nucleic acid molecule that hybridizes under stringent hybridization conditions with macrophase migration inhibiatory factor (MIF) gene selected from dirofilaria immitis MIF gene and Onchocerca volvulus MIF gene |
| 09/13/2001 | US20010021516 An isolated nucleic acid molecule comprising a polynucleotide having nucleotide sequence atleast 95% identical to a sequence selected from a nucleotide sequence encoding a TRID polypeptide having specific amino acid sequence |
| 09/13/2001 | US20010021512 Microsporidian polar tube proteins, nucleic acids coding for these proteins and their applications |
| 09/13/2001 | US20010021511 Contacting a stool sample obtained from the mammal with a capture reagent ( an antibody) which binds to a 29 KDa antigen of Entamoeba histolytica to form a complex with 29 KDa antigen if present in the stool sample |
| 09/13/2001 | US20010021507 Renal nuclear matrix protein able to differentiate cancerous renal cell from normal renal cells; useful for diagnosis and producing treatment for cell proliferative disorders of the kidney |
| 09/13/2001 | US20010021505 ALK protein tyrosine kinase/receptor and ligands thereof |
| 09/13/2001 | US20010021502 Detecting an alteration in an A-T gene which is associated with breast cancer in a human, if the alteration is in germline it is associated with predisposition to breast cancer and if it is in somatic tissue it indicates cancer |
| 09/13/2001 | US20010021393 Antibodies from eggs immunized with urease of Helicobacter |
| 09/13/2001 | US20010021383 Antibodies for diagnosis, therapy |
| 09/13/2001 | US20010021382 Monoclonal antibodies |
| 09/13/2001 | US20010021381 Administering tumor necrosis factor antibody |
| 09/13/2001 | DE10010938A1 Anorganische Pyrophosphatasen aus Lepidopteren Inorganic pyrophosphatase of Lepidoptera |
| 09/13/2001 | CA2723031A1 Polypeptides having neutrophil stimulating activity |
| 09/13/2001 | CA2402896A1 Polypeptide inducing apoptosis |
| 09/13/2001 | CA2402412A1 Human extracellular signal regulated kinases |
| 09/13/2001 | CA2402214A1 T1r taste receptors and genes encoding same |
| 09/13/2001 | CA2402211A1 Phosphatidyl serine receptors and uses thereof |
| 09/13/2001 | CA2402081A1 A compound that selectively binds to cd123 and use thereof to kill hematologic cancer progenitor cells |
| 09/13/2001 | CA2401964A1 New abc transporter atil |
| 09/13/2001 | CA2401549A1 G-protein coupled receptor related polypeptides |
| 09/13/2001 | CA2401541A1 Human protein kinases and protein kinase-like enzymes |
| 09/13/2001 | CA2401454A1 G-protein coupled receptors |
| 09/13/2001 | CA2401398A1 Dna encoding human acid-sensing ion channel bnac4 (asic4) |
| 09/13/2001 | CA2401323A1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 09/13/2001 | CA2400628A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function |
| 09/13/2001 | CA2400504A1 Composition for the treatment of heart failure |
| 09/13/2001 | CA2399943A1 Immune system-related polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | CA2399921A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | CA2399913A1 Adam polynucleotides, polypeptides, and antibodies |
| 09/12/2001 | EP1132476A1 Inorganic Pyrophosphatases from Lepidoptera |
| 09/12/2001 | EP1132471A2 TNF-binding proteins |
| 09/12/2001 | EP1132468A1 MAST CELL-SPECIFIC SIGNAL TRANSDUCING MOLECULES AND cDNAS THEREOF |
| 09/12/2001 | EP1132401A1 HUMAN PROTEINS STAM2a AND STAM2b AND cDNAS ENCODING THESE MOLECULES |
| 09/12/2001 | EP1132097A2 Cellular and serum protein anchors and conjugates |
| 09/12/2001 | EP1132092A1 Coupling factor 6 inhibitor and potentiator and use thereof |
| 09/12/2001 | EP1131636A1 Antibodies to peptides that target git receptors and related methods |
| 09/12/2001 | EP1131635A1 An immunoassay for the determination of transmissible spongiform encephalopathies in bovine |
| 09/12/2001 | EP1131467A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 09/12/2001 | EP1131452A2 Nucleic acid molecules from rice and their use for the production of modified starch |
| 09/12/2001 | EP1131445A1 Human phospholipases |
| 09/12/2001 | EP1131443A2 Human hydrolase proteins |
| 09/12/2001 | EP1131433A1 Members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
| 09/12/2001 | EP1131429A1 Calcium binding protein |
| 09/12/2001 | EP1131428A2 Immunoglobulin superfamily proteins |
| 09/12/2001 | EP1131427A1 Mammalian chondromodulin-like protein |
| 09/12/2001 | EP1131426A2 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides |
| 09/12/2001 | EP1131425A2 Inflammation-associated genes |
| 09/12/2001 | EP1131424A2 Mutation of the parkin gene, compositions, methods and uses |
| 09/12/2001 | EP1131411A2 Suppression of xenotransplant rejection |
| 09/12/2001 | EP1131358A1 Humanized antibody specific for surface antigen pre-s1 of hbv and preparation method thereof |
| 09/12/2001 | EP1131357A1 Humanized antibody specific for human 4-1bb and pharmaceutical composition comprising same |
| 09/12/2001 | EP1131356A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies |
| 09/12/2001 | EP1131355A1 Method for producing antibodies acting against a polypeptide that only recognises the coding nucleic acid |
| 09/12/2001 | EP1131354A1 Contraceptive antibody vaccines |
| 09/12/2001 | EP1131350A1 Egf-like nucleic acids and polypeptides and uses thereof |
| 09/12/2001 | EP1131349A2 Potassium channel interactors and uses therefor |
| 09/12/2001 | EP1131347A2 Product |
| 09/12/2001 | EP1131346A1 Heliobacter pylori antigen |
| 09/12/2001 | EP1131344A2 Retro-inversion peptides that target git transport receptors and related methods |
| 09/12/2001 | EP1131333A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ENCODE T CELL INDUCIBLE FACTORS (TIFs), THE PROTEINS ENCODED, AND USES THEREOF |
| 09/12/2001 | EP1131106A1 Compositions and methods for producing vascular occlusion |
| 09/12/2001 | EP1131098A1 Cd25 binding molecules for use in the treatment of manifestations of rejection in transplantation |
| 09/12/2001 | EP1131097A1 Anti-icam-r antibody-induced apoptosis |
| 09/12/2001 | EP1131096A1 Chimeric anti-cd20 antibody treatment of patients receiving bmt or pbsc transplants |
| 09/12/2001 | EP1131095A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 09/12/2001 | EP1131093A1 Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-cd20 antibody |
| 09/12/2001 | EP1131090A2 Method of using pon-1 to decrease atheroma formation |
| 09/12/2001 | EP1131086A2 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto |
| 09/12/2001 | EP1131084A1 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists |
| 09/12/2001 | EP1131079A1 Small functional units of antibody heavy chain variable regions |
| 09/12/2001 | EP1130969A1 Murf2 polypeptides and polynucleotides |
| 09/12/2001 | EP0991423B1 Topical treatment of psoriasis using neutralizing antibodies to il-8 |
| 09/12/2001 | EP0804452B1 Recombinant c140 receptor, its agonists and antagonists |
| 09/12/2001 | EP0766736B1 Human monoclonal antibodies specific to cell cycle independent glioma surface antigen |
| 09/12/2001 | EP0704056B1 Leukocyte adhesion assay |
| 09/12/2001 | EP0687300B1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T-CELL ACTIVATION AND PROLIFERATION |
| 09/12/2001 | EP0586474B1 Peptide nucleic acids |
| 09/12/2001 | CN1312723A Compound and method for diagnosis of tuberculosis |
| 09/12/2001 | CN1312380A Human unwinding enzyme 10 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312377A Human unwinding enzyme 69 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312295A Flocculation charification-ultrafiltration concentration process of producing composite immunoreactive protein |